Biotech
AI / ML
Lila Sciences aims to bridge the divide between prediction and validation across the life sciences, materials science, and chemicals. Its Autonomous Science platform pairs AI models trained on the scientific method with automated experimentation in AI Science Factories to produce novel therapeutics, technologies, and compounds. These assets can then be transferred to enterprise partners through licensing or collaboration, for further development.
Scaling Biology 004: Lila Sciences' and Expedition's Co-founder Molly Gibson on AI Scientific Discovery
Announcing Lila’s $350M Series A and Incredible Partners on Our Mission
Emerging technologies in healthcare, part 3: Lila Sciences
How Lila Is Redefining Scientific Discovery With Geoffrey von Maltzahn
The Quest for A.I. ‘Scientific Superintelligence’
Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science